Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
California Medicaid was one of the first to cover Wegovy, spending nearly $1 billion before rebates on more than 720,000 prescriptions from 2022 through the end of 2024, according to a Reuters tally of federal data
Verify current pricing on the official website before making decisions
Shel Wellness & Aesthetic Center, well give you a thorough consultation about your concerns and needs
Unlike earlier-generation weight-management agents, retatrutide is a triple receptor agonist , meaning it simultaneously activates three distinct hormonal receptors: GLP-1 (glucagon-like peptide-1) receptor promotes insulin secretion, reduces appetite, and slows gastric emptying [9] [10] GIP (glucose-dependent insulinotropic polypeptide) receptor enhances insulin release and may improve fat metabolism [12] [13] Glucagon receptor increases energy expenditure and may reduce hepatic steatosis, as suggested by imaging data (MRI-PDFF) from Phase 2 trials, though this effect requires confirmation in larger studies [2] [5] This triple-agonist mechanism distinguishes retatrutide from agents such as semaglutide (GLP-1 only) or tirzepatide (GLP-1/GIP dual agonist), and is thought to produce more pronounced reductions in body weight and improvements in metabolic parameters
US$ 28.52
US$ 24.20
US$ 25.58
US$ 22.66
US$ 23.62
US$ 28.61
US$ 25.53
US$ 25.96
US$ 21.74
US$ 23.81
